Health-related quality of life in diabetes: The associations of complications with EQ-5D scores
Oddvar Solli, Knut Stavem, I S Kristiansen, Oddvar Solli, Knut Stavem, I S Kristiansen
Abstract
Background: The aim of this study was to describe how diabetes complications influence the health-related quality of life of individuals with diabetes using the individual EQ-5D dimensions and the EQ-5D index.
Methods: We mailed a questionnaire to 1,000 individuals with diabetes type 1 and 2 in Norway. The questionnaire had questions about socio-demographic characteristics, use of health care, diabetes complications and finally the EQ-5D descriptive system. Logistic regressions were used to explore determinants of responses in the EQ-5D dimensions, and robust linear regression was used to explore determinants of the EQ-5D index.
Results: In multivariate analyses the strongest determinants of reduced MOBILITY were neuropathy and ischemic heart disease. In the ANXIETY/DEPRESSION dimension of the EQ-5D, "fear of hypoglycaemia" was a strong determinant. For those without complications, the EQ-5D index was 0.90 (type 1 diabetes) and 0.85 (type 2 diabetes). For those with complications, the EQ-5D index was 0.68 (type 1 diabetes) and 0.73 (type 2 diabetes). In the linear regression the factors with the greatest negative impact on the EQ-5D index were ischemic heart disease (type 1 diabetes), stroke (both diabetes types), neuropathy (both diabetes types), and fear of hypoglycaemia (type 2 diabetes).
Conclusions: The EQ-5D dimensions and the EQ-5D seem capable of capturing the consequences of diabetes-related complications, and such complications may have substantial impact on several dimensions of health-related quality of life (HRQoL). The strongest determinants of reduced HRQoL in people with diabetes were ischemic heart disease, stroke and neuropathy.
References
- Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. doi: 10.2337/diacare.27.5.1047.
- Grandy S, Fox K. EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) Health and Quality of Life Outcomes. 2008;6:18. doi: 10.1186/1477-7525-6-18.
- Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M. Health-related quality of life in type 2 diabetes (TARDIS-2) Value Health. 2000;3(Suppl 1):47–51. doi: 10.1046/j.1524-4733.2000.36028.x.
- Koopmanschap M. Coping with Type II diabetes: the patient's perspective. Diabetologia. 2002;45:S18–S22.
- Wexler D, Grant R, Wittenberg E, Bosch J, Cagliero E, Delahanty L. Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006;49:1489–1497. doi: 10.1007/s00125-006-0249-9.
- Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999;8:79–91. doi: 10.1023/A:1026485130100.
- Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG. Development and validation of the Diabetes Care Profile. Eval Health Prof. 1996;19:208–230. doi: 10.1177/016327879601900205.
- Hirsch A, Bartholomae C, Volmer T. Dimensions of quality of life in people with non-insulin-dependent diabetes. Quality of Life Research. 2000;9:207–218. doi: 10.1023/A:1008959810698.
- Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483. doi: 10.1097/00005650-199206000-00002.
- EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
- Sintonen H. [Health-related quality of life measures] Sairaanhoitaja. 1993. pp. 17–19.
- Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375–384. doi: 10.3109/07853890109002092.
- Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health and Quality of Life Outcomes. 2003;1:54. doi: 10.1186/1477-7525-1-54.
- Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics. 2002;21:271–292. doi: 10.1016/S0167-6296(01)00130-8.
- Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res. 1972;7:118–133.
- Klarman HEPh, Francis JO, Rosenthal GDP. Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease. [Article] Medical Care. 1968;6:48–54. doi: 10.1097/00005650-196801000-00005.
- Glasziou P, Alexander J, Beller E, Clarke P. the ADVANCE Collaborative Group. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health and Quality of Life Outcomes. 2007;5:21. doi: 10.1186/1477-7525-5-21.
- Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–1108. doi: 10.1097/00005650-199711000-00002.
- Speight J, Reaney MD, Barnard KD. Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med. 2009;26:315–327. doi: 10.1111/j.1464-5491.2009.02682.x.
- Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care. 1999;22:1125–1136. doi: 10.2337/diacare.22.7.1125.
- Matza LS, Boye KS, Yurgin N, Brewster-Jordan J, Mannix S, Shorr JM. Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res. 2007;16:1251–1265. doi: 10.1007/s11136-007-9226-0.
- Dennett SL, Boye KS, Yurgin NR. The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Health. 2008;11:478–486. doi: 10.1111/j.1524-4733.2007.00260.x.
- Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res. 2001;10:621–635. doi: 10.1023/A:1013171831202.
- Norinder AGPK. In: Proceedings of the 18th Plenary Meeting of the EuroQol Group. Roos P, editor. 2002. Estimating Danish EuroQol tariffs using the Time Trade off (TTO) and Visula Analogue Scale (VAS) Methods; pp. 257–292.
- Nord E. EuroQol®: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy. 1991;18:25–36. doi: 10.1016/0168-8510(91)90141-J.
Source: PubMed